-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师总结如下：PINS第一季度业绩超出预期，营收达10.08亿美元（同比增长18%），高于市场普遍预期的9.68亿美元；调整后EBITDA为2.07亿美元（利润率为20%），高于此前预测的1.76亿美元。该公司连续第十个季度实现两位数用户增长，全球月活跃用户数达到6.31亿（同比增长11%），这主要得益于其平台在不同人群和地区持续的吸引力。国际市场表现强劲，欧洲营收同比增长27%至1.86亿美元，世界其他地区营收同比增长59%至7200万美元；同时，每用户平均收入（ARPU）增长依然强劲，欧洲ARPU增长17%，世界其他地区ARPU增长38%，验证了其国际化商业化战略的有效性。公司第二季度营收预期为11.33亿美元至11.53亿美元（同比增长14%-16%），高于市场普遍预期的11.23亿美元。公司完成了20亿美元的股票回购计划，并发行了9.85亿美元的可转换债券，导致现金储备从25亿美元减少至13亿美元。尽管进行了战略性的人工智能和产品开发投资，公司第一季度仍实现了3.12亿美元的强劲自由现金流。
Related Articles
Asia
Westpac's Total Capital, CET1 Capital Up Year on Year in March Quarter
Westpac Banking (ASX:WBC, NZE:WBC) total capital and Common Equity Tier 1 (CET1) capital both increased year-over-year in the March quarter, according to a Tuesday Australian bourse filing.The bank's total capital in the three months to March came in at AU$98.54 billion, up from the AU$97.14 billion it reported in the year-ago period. Its CET1 capital for the period clocked in at AU$56.94 billion, rising from the AU$55.01 billion it reported for the March 2025 quarter.Its CET1 ratio for the March quarter was 12.4%, compared with a ratio of 12.2% in the prior-year period. It reported a liquidity coverage ratio of 132% for the quarter, compared with 135% in the same period in the previous year.
$ASX:WBC$NZE:WBC
Research
Research Alert: CFRA Raises Opinion On Shares Of Gildan Activewear To Buy From Hold
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We maintain our 12-month price target of CAD98, based on 16.0x our 2026 EPS estimate and above the company's five-year average forward P/E multiple of 12.9x, reflecting our view that the company deserves an above-peer multiple. We view the recent acquisition of HanesBrands as positive and believe the company will improve Hanes' operating efficiency while capitalizing on significant synergies. GIL reported Q1 2026 results that reflect the significant impact of its HanesBrands acquisition, with revenues increasing 64% to $1.17B, $18M above estimates, while facing substantial integration-related charges. Adjusted EPS from continuing operations declined to $0.43 from $0.59, $0.08 above consensus estimates, reflecting higher share count from the acquisition and ongoing integration expenses. We now view shares more positively after a 20% decline from its 52-week high just a few months ago. Shares currently trade at 13.5x the midpoint of the company's full-year EPS guidance.
$GIL
Asia
Medibank Private Reports Policyholder Growth in Nine Months to March 31, Maintains Outlook
Medibank Private (ASX:MPL) reported policyholder growth of 22,400 in its resident private health insurance business in the nine months to March 31, up 25% from the same period a year earlier, according to a Tuesday filing with the Australian bourse.The company said the resident private health insurance industry has become more competitive in recent months, with data showing consumers increasingly prioritizing value and some participants resorting to price-led customer propositions."While no new material trends have emerged in 2026, Medibank will continue to monitor utilization given historic behavior and competitor activity as we remain disciplined," it said.Medibank maintained its fiscal 2026 guidance, saying it does not expect global events and volatility to have a direct impact on its businesses.The company's main financial exposure is through its investment portfolio, which includes about AU$188 million of investments in equities, and through movements in Australia's cash rate where it flagged a roughly AU$7 million annual impact to investment income.
$ASX:MPL